Cutler Group LP Ocular Therapeutix, Inc Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 10, 2018	SELL	$5.99 - $8.17 $7,188 - $9,804	-1,200 Reduced 44.44%	1,500 $0
Q1 2018 May 11, 2018	SELL	$4.66 - $7.08 $13,514 - $20,532	-2,900 Reduced 51.79%	2,700 $1,000
Q4 2017 Jan 17, 2018	SELL	$3.73 - $6.37 $5,222 - $8,918	-1,400 Reduced 20.0%	5,600 $1,000
Q3 2017 Oct 17, 2017	BUY	$5.28 - $6.88 $36,960 - $48,160	7,000	7,000 $1,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $514M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.